Repare Therapeutics Inc. , a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today.
Repare Therapeutics Insiders Establish Automatic Securities Disposition Plans streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Repare Therapeutics Insiders Establish Automatic Securities Disposition Plans valdostadailytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from valdostadailytimes.com Daily Mail and Mail on Sunday newspapers.
Repare Therapeutics Insiders Establish Automatic Securities Disposition Plans joplinglobe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from joplinglobe.com Daily Mail and Mail on Sunday newspapers.
RP-1664 demonstrated potent and selective inhibition of PLK4 and synthetic lethality in TRIM37-high tumor cells in preclinical studies
RP-3467 demonstrated complete, sustained regressions.